Novel Coating Approaches for Polyethylene Biliary Stents to Reduce Microbial Adhesion, Prevent Biofilm Formation, and Prolong Stent Patency
<b>Background</b>: Occlusion of plastic biliary stents is a common complication in biliary drainage, often requiring exchange procedures every 2-4 months due to microbial colonization and sludge formation. This study aimed to evaluate diamond-like carbon (DLC) coatings, with and without silver nanoparticle additives, for preventing stent occlusion. <b>Methods</b>: Polyethylene (PE) stents were coated with DLC using PlasmaImpax for DLC-1 and pulsed laser deposition for DLC-2. Silver ions (Ag) were incorporated into the DLC-2 coatings. To simulate in vivo conditions, a co-culture of <i>Enterococcus faecalis (E. faecalis)</i>, <i>Escherichia coli (E. coli),</i> and <i>Candida albicans (C. albicans)</i> was used for microbial colonization. Standardized human bile simulated physiological conditions. Adhesion tests, weight measurements, and scanning electron microscopy (SEM) quantified bacterial adherence to stents. <b>Results</b>: DLC-1 coatings demonstrated higher bacterial growth than uncoated PE stents with <i>E. faecalis</i> (adhesion assay difference: 0.6 log [<i>p</i> = 0.19] and 0.1 log [<i>p</i> = 0.75] in rounds 1 and 2, respectively). In the bile incubation model, DLC-1 did not significantly reduce bacterial counts at 5 days (0.4 log [<i>p</i> = 0.06]) or 14 days (0.2 log [<i>p</i> = 0.44]). DLC-2 showed no significant reduction either. DLC-2-Ag significantly reduced bacterial adhesion (5 days: -0.3 log [<i>p</i> = 0.00]; 14 days: -0.4 log [<i>p</i> = 0.16]) and exhibited inhibition zones against <i>E. faecalis</i> (2.3 mm), <i>E. coli</i> (2.1 mm), and <i>C. albicans</i> (0.6 mm). SEM revealed cracks and flaking in the coating. <b>Conclusions</b>: DLC coatings alone did not prevent microbial adhesion. Tendencies of anti-adhesive properties were seen with Ag-doped DLC coatings, which were attributed to the antibacterial effects of Ag. Optimization of the DLC-coating process is needed to improve stent performance. Future studies with larger samples sizes are needed to confirm the observed trends.
Authors
- Dominik Pförringer (ORCID: https://orcid.org/0000-0002-0682-8293)
- Andreas Obermeier (ORCID: https://orcid.org/0000-0002-1774-5194)
- D Schippers (ORCID: https://orcid.org/0000-0002-9303-1716)
- Laura Wagner (ORCID: https://orcid.org/0000-0002-5184-8154)
- Jutta Tuebel (ORCID: https://orcid.org/0000-0001-5033-2191)
- Rainer Burgkart (ORCID: https://orcid.org/0000-0002-9107-4229)
- Jochen Schneider (ORCID: https://orcid.org/0000-0002-0300-0159)
- Roland M. Schmid (ORCID: https://orcid.org/0000-0002-5751-7313)
- Philipp Stolte
- Stephan Heller
Institutions
- Tumaini University (TZ)
- Tumkur University (IN)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-08-09
- DOI
- https://doi.org/10.3390/biomedicines13081950
- Primary Topic
- Gallbladder and Bile Duct Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00